Syngenta IPO: Revenue, Statistics, Valuation & How to Invest

What is Syngenta?

Syngenta is a science-based AgTech firm that provides farmers across the world with advanced solutions for protecting crops and improving crop productivity to create more efficient and sustainable agriculture businesses.

What’s particularly interesting about Syngenta is that it is no small, bootstrapped start-up. The firm was initially created through a merger between Novartis Agribusiness and Zeneca Agrochemicals in 2000. This allowed Syngenta to hit the ground running and operate at the necessary scale to make the business viable.

The company was listed on the New York Stock Exchange (NYSE) and the SIX Swiss Exchange, but was taken private after being acquired by the Chinese state-owned ChemChina in 2017 for $43 billion. The shares were delisted from the US and Swiss stock exchanges when this happened.

In 2020, Syngenta was combined with ADAMA and the agricultural businesses of Sinochem to form Syngenta Group, headquartered in Basel. ChemChina and Sinochem then merged in 2021 into Sinochem Holdings, which now owns the group. Syngenta Group has a long history of publishing its financials (unlike most private companies) and today has more than 50,000 employees in over 90 countries, with sales of $28.4 billion in 2025.

Syngenta Key Company Facts

Syngenta Company Statistics

Below is a breakdown of some key information, including Syngenta’s sales figures, profit, and top competitors.

Syngenta Sales Revenue

Below is a breakdown of Syngenta’s two primary sources of sales revenue up to 2023: crop protection and seed sales.

Since 2024, Syngenta Group reports four business units, so the figures below are not directly comparable with the table above. In 2025, group sales fell 1% to $28.4 billion, while EBITDA (earnings before interest, taxes, depreciation and amortisation) rose 13% to $4.4 billion.

Syngenta Profit (net income)

Syngenta’s competitors

Few companies can do what Syngenta does on such scale. These are its key competitors:

• Bayer Crop Science (which absorbed Monsanto in 2018)
• Corteva (the former agricultural business of DowDuPont)
• BASF Agricultural Solutions
• FMC
• UPL
• KWS (seeds)

ADAMA, often listed as a competitor, has been part of Syngenta Group since 2020.

When is the Syngenta IPO?

No date is set, and the most recent reports point to 2027 at the earliest. The listing has been delayed several times:

• 2021: Syngenta Group applied to list on the Shanghai Stock Exchange’s main board, aiming to raise about $10 billion.
• March 2024: after a three-year wait, Syngenta withdrew its Shanghai IPO application, citing the industry environment and its own development strategy. It said it would restart the process in China or on another exchange when conditions were right.
• February 2026: reports said Syngenta was targeting a Hong Kong listing of up to $10 billion in 2026.
• July 2026: Bloomberg reported that the IPO, now sized at about $5 billion, was pushed back to 2027, as Middle East tensions disrupted fertiliser and crop markets. CEO Jeff Rowe, a leading supporter of the IPO, stepped down in August and was replaced by chief operating officer Hengde Qin.
• September 2026: Syngenta reportedly filed confidentially for a Hong Kong IPO of about $5 billion, aiming to list next year subject to regulatory approval. Syngenta declined to comment.

Regulatory approval is the main hurdle. Seed production is considered a sensitive industry in China, so the listing may need extra sign-offs. Until Syngenta publishes a prospectus, the size, timing and price of the offering can still change.

How to invest and buy shares after the Syngenta IPO

If Syngenta lists in Hong Kong, you will need a broker with access to the Hong Kong Stock Exchange (HKEX). Interactive Brokers and eToro both offer Hong Kong-listed stocks, so they are good candidates to buy Syngenta shares once they start trading. Take a look at both brokers below:

1. Interactive Brokers

Founded in 1978, Interactive Brokers (IBKR) gives you access to 170 markets in 40 countries, including the Hong Kong Stock Exchange, and more than 5.5 million client accounts use it to trade stocks, bonds, ETFs, forex, funds, options and futures.

If you want to buy Syngenta stock after the IPO, here’s how you can buy shares using Interactive Brokers:

1. Open a trading account with Interactive Brokers.
2. Deposit funds into your account.
3. Once it’s listed, search for Syngenta. There is no confirmed ticker symbol yet.
4. Choose your order type (for example market, limit or stop).
5. Once you’ve bought your desired number of Syngenta shares, continue to monitor performance.

If you’d like to learn more about the IBKR platform, check out our full-length Interactive Brokers review.

2. eToro

eToro is a multi-asset investment platform with more than 4 million funded accounts, best known for its social and copy trading features. It offers stocks, including Hong Kong-listed shares, ETFs and other assets.

If you’re planning to buy Syngenta stock after the IPO, here’s how you can buy shares using eToro:

1. Open an account with eToro.
2. Head to the ‘Markets’ page and select ‘Stocks’.
3. Search for the Syngenta stock and select ‘Trade’.
4. Next, hit ‘BUY’.
5. Choose how much you want to invest in Syngenta or the number of shares you want to buy.
6. Decide on a take-profit parameter if you want to automate a future sale of your Syngenta stock.
7. Finally, hit ‘Open Trade’.

If you’d like to learn more about eToro, check out our in-depth eToro review.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 55% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Bottom line on investing in the Syngenta IPO

Investors could own Syngenta shares until ChemChina took the company private in 2017. A return to the stock market now looks likely, but on a longer timeline than once expected: after withdrawing its Shanghai application in 2024, Syngenta has reportedly filed confidentially for a Hong Kong IPO of about $5 billion, with a listing most likely in 2027.

Unlike most IPO candidates, Syngenta has a long record of published financials. In 2025, Syngenta Group made $28.4 billion in sales and $4.4 billion in EBITDA, and it targets a 20% EBITDA margin by the end of 2026. A long track record does not remove the risks of investing in a new listing, though.

The main question marks are about the shareholder and the regulator. Sinochem Holdings, a Chinese state-owned company, will very likely keep control after the IPO, and the listing needs regulatory approval in a sector China treats as sensitive. Until a prospectus is published, the size, timing and price of the offering remain uncertain.